Supply Chain

Walgreens, in partnership with drugmaker Kaleo, will be the first retail pharmacy to offer Auvi-Q, an alternative to EpiPen, in an effort to combat the nationwide shortage of the lifesaving allergy drug, according to The Wall Street Journal.

Salt Lake City-based Intermountain Healthcare honored four of its suppliers for their exceptional contributions to the health system's cost, care quality and patient outcomes.

Seven major health systems, representing about 500 hospitals, have teamed up to form a nonprofit company named Civica Rx to manufacture their own generic medicines.

Alcon, a subsidiary of Novartis that focuses on manufacturing eye-care products, withdrew its CyPass Micro-Stent from the global market after a long-term safety study. The devicemaker also advised surgeons to immediately stop using the product.

Deerfield, Ill.-based Baxter International, a medical devicemaker, will lay off 131 employees at its facility in Medina, N.Y., according to Buffalo Business First.

It's no secret the healthcare industry is evolving amid reimbursement changes, care shifting to non-acute settings and four generations of patients all seeking healthcare at once. Stuck between old and new technologies, the industry is trying to find the balance…

Here are four drugs or medical devices that have been approved by the FDA since Aug. 24:

Oakland, Calif.-based Kaiser Permanente is altering an EpiPen prescription policy after reportedly receiving complaints from patients, according to a CBS SF Bay Area investigation.

The Blood Bank of Hawaii is urgently seeking blood donors after severe weather pummeled the region and depleted supplies, according to Hawaii News Now.

As Hurricane Irma bore down on Florida, officials at Baptist Health South Florida—a health system with 10 acute care in-patient facilities; more than 70 outpatient facilities including urgent care, imaging and surgery center locations; and more than 41 physician offices…